XENXENITRA LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 19:37 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 18 Aug 2026, 19:47 | $5m Offtake Agreement Expands OTC-Medicine Business | Company Update | MS | 11001 | |
| 30 July 2026, 21:24 | Investor Presentation | Presentations | — | 03026 | |
| 30 July 2026, 18:30 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 28 July 2026, 18:40 | Investor Webinar | Presentations | — | 14014 | |
| 27 July 2026, 18:55 | $12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL | Company Update | MS | 11001 | |
| 10 June 2026, 19:31 | Xenitra Investor Webinar | Presentations | — | 14014 | |
| 4 June 2026, 19:08 | $1.1m in OPAL-Tokenised Product Sales in First 7 Weeks | Company Update | MS | 11001 | |
| 2 June 2026, 18:23 | XEN Appointed as Exclusive Biomiq Skincare China Distributor | Company Update | MS | 11001 | |
| 20 May 2026, 02:34 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 20 May 2026, 02:31 | Application for quotation of securities - XEN | Other | — | 06020 | |
| 14 May 2026, 19:19 | Product sales of $500k in first month of OPAL token launch | Company Update | MS | 11001 | |
| 7 May 2026, 20:08 | Investor Presentation | Presentations | — | 03026 | |
| 7 May 2026, 19:21 | Proposed issue of securities - XEN | Securities Administration | — | 06013 | |
| 7 May 2026, 19:21 | $1.25m Raised to Support Next Phase of Growth | Capital Raising | MS | 06003, 09014 | |
| 5 May 2026, 20:49 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 5 May 2026, 19:54 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 1 May 2026, 03:10 | Change of Address | Securities Administration | — | 12002, 12003 | |
| 1 May 2026, 02:23 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 21 Apr 2026, 18:16 | OPAL token launch of EZZ products sells $100k in first week | Company Update | MS | 11001 | |
| 16 Apr 2026, 19:12 | Q3 Sales rise by over 305% to $8.3m | Periodic Reports | MS | 03014 | |
| 15 Apr 2026, 19:20 | Acquisition of Fukang OTC Pharmacy | Mergers & Acquisitions | MS | 07001 | |
| 10 Apr 2026, 03:10 | Change of Director's Interest Notice - ZG | Director Interests | — | 02009 | |
| 10 Apr 2026, 03:10 | Change of Director's Interest Notice - LL | Director Interests | — | 02009 | |
| 10 Apr 2026, 03:09 | Change of Director's Interest Notice - CH | Director Interests | — | 02009 | |
| 10 Apr 2026, 03:08 | Change of Director's Interest Notice - AN | Director Interests | — | 02009 | |
| 9 Apr 2026, 03:02 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 9 Apr 2026, 02:53 | Application for quotation of securities - XEN | Other | — | 06020 | |
| 7 Apr 2026, 19:44 | Notification regarding unquoted securities - XEN | Other | — | 06021 | |
| 7 Apr 2026, 19:44 | Notification regarding unquoted securities - XEN | Other | — | 06021 | |
| 7 Apr 2026, 19:44 | Notification regarding unquoted securities - XEN | Other | — | 06021 | |
| 7 Apr 2026, 19:43 | OPAL Token & Xen Shop Launch - Next-Gen Digital Commerce | Company Update | MS | 11001 | |
| 3 Apr 2026, 05:18 | Notification regarding unquoted securities - XEN | Other | — | 06021 |
1–33 of 33
1 / 1